Cain, L., Li, Y., Liu, H., Christensen, S., Myers, R., Leahy, A. B., Diorio, C., Shapiro, N., McBride, E., Callahan, C., Baniewicz, D., DiNofia, A., Rheingold, S., Wray, L., Hunger, S., Aplenc, R., McClory, S., Stewart, M., Wertheim, G., Fesnak, A., Plesa, G., Siegel, D., Fraietta, J., Gonzalez, V., Hopkins, C., Marshall, A., Kotch, A., Levine, B., Chew, A., Hexner, E., June, C., Grupp, S., Maude, S. (2025). Humanized CD19 chimeric antigen receptor (CAR) T-cell therapy for high-risk and post-CAR relapse of B-cell acute lymphoblastic leukemia. Blood. https://doi.org/10.1182/blood-2025-646